Phase II trial of ALX 0141 in patients with bone metastases.
Phase of Trial: Phase II
Latest Information Update: 25 May 2011
At a glance
- Drugs ALX 0141 (Primary)
- Indications Bone metastases; Cancer
- Focus Therapeutic Use
- Sponsors Ablynx
- 25 May 2011 This trial is expected to start by the end of 2011, according to an Ablynx media release.
- 23 Sep 2010 New trial record
- 20 Sep 2010 This trial is expected to commence in the second half of 2011, according to an Ablynx media release.